Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Molecular Profiling of Decitabine Response in MDS and AML Patients

Pawan Kumar Upadhyay, PhD, Jeremy Beales, MS, Nakul Kumar Shah, MD, Christopher A Miller, PhD, Allegra A Petti, PhD, Daniel C. Link, MD, Timothy J Ley, MD, John Welch, MDPhD

Blood (2020) 136 (Supplement 1): 40.

https://doi.org/10.1182/blood-2020-141292

Published: 2020

Journal Articles

Signaling Gene Mutations Are Characterized By Diverse Patterns of Expansion and Contraction during Progression from MDS to Secondary AML

Andrew J Menssen, BA, Ajay Khanna, Christopher A Miller, PhD, Gue Su Chang, PhD, Jin J Shao, Sridhar Nonavinkere Srivatsan, MS, Joshua Robinson, Michelle O'Laughlin, Catrina Fronick, BS, Robert Fulton, MS, Kimberly J Brendel, Sharon E Heath, Peter Westervelt, MDPhD, John F. DiPersio, MD PhD, Daniel C. Link, MD, Meagan A. Jacoby, Eric Duncavage, MD, Timothy J Ley, MD, Matthew J. Walter, MD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-140394

Published: 2020

Journal Articles

Gata2 Expression and Function in PML-RARA- driven Preleukemia and APL

Casey D.S. Katerndahl, PhD, Timothy J Ley, MD, Michelle A Cai, Timothy P Rooney, Jr., Sai Mukund Ramakrishnan, MS, Sridhar Nonavinkere Srivatsan, MS, Christopher A Miller, PhD

Blood (2019) 134 (Supplement_1): 534.

https://doi.org/10.1182/blood-2019-131883

Published: 2019

Journal Articles

DNMT3A R882 Alters the Epigenome of Hematopoietic Cells

Amanda M Smith, PhD, Taylor LaValle, BS, Shamika Ketkar, PhD, Sai Mukund Ramakrishnan, MS, Christopher A Miller, PhD, Timothy J Ley, MD

Blood (2019) 134 (Supplement_1): 112.

https://doi.org/10.1182/blood-2019-129003

Published: 2019

Journal Articles

The Molecular Basis of Long First Remissions in Normal Karyotype AML Patients

Francesca Ferraro, MD PhD, Christopher A Miller, PhD, Amy Abdalla, Nichole Helton, Nathan Salomonis, PhD, Robert S Fulton, Catrina Fronick, BS, Sharon E Heath, Peter Westervelt, MD PhD, Timothy J Ley, MD

Blood (2019) 134 (Supplement_1): 3827.

https://doi.org/10.1182/blood-2019-122967

Published: 2019

Journal Articles

The Role of Transcription Factor and Signaling Gene Mutations in the Clonal Evolution of MDS to Secondary AML

Andrew E Menssen, BA, Christopher A Miller, PhD, Ajay J Khanna, Gue Su Chang, PhD, Jin J Shao, Sridhar Nonavinkere Srivatsan, MS, Joshua Robinson, Kimberly J Brendel, Sharon E Heath, Eric J. Duncavage, MD, Matthew J. Walter, MD

Blood (2018) 132 (Supplement 1): 4338.

https://doi.org/10.1182/blood-2018-99-119798

Published: 2018

Journal Articles

Direct Detection of Expressed Mutations in AML Cells Using Single Cell RNA-Sequencing, and Its Impact on Defining Sources of Expression Heterogeneity

Allegra A Petti, PhD, Stephen R Williams, PhD, Christopher A Miller, PhD, Ian T Fiddes, PhD, David Chen, MD PhD, Sridhar Nonavinkere Srivatsan, MS, Catrina Fronick, BS, Robert Fulton, MS, Deanna M Church, PhD, Timothy J Ley, MD

Blood (2018) 132 (Supplement 1): 1314.

https://doi.org/10.1182/blood-2018-99-119075

Published: 2018

Journal Articles

Evidence for Complete Mutation Clearance in Normal Karyotype AML Patients with Very Long (> 5 years) Remissions after Chemotherapy Alone

Francesca Ferraro, MD PhD, Christopher A Miller, PhD, Nichole Helton, Robert S Fulton, Catrina Fronick, BS, Sharon E Heath, Peter Westervelt, MD PhD, Timothy J Ley, MD

Blood (2018) 132 (Supplement 1): 1503.

https://doi.org/10.1182/blood-2018-99-117288

Published: 2018

Journal Articles

Generation and Characterization of Murine Allogeneic T Cell Resistant APL Cells

Ezhilarasi Chendamarai, PhD, Michael P Rettig, PhD, Gue Su Chang, PhD, Allegra A Petti, PhD, Christopher A Miller, PhD, Julie Ritchey, Lukas D Wartman, MD, Timothy J Ley, MD, John F DiPersio, MD PhD

Blood (2017) 130 (Supplement 1): 3170.

https://doi.org/10.1182/blood.V130.Suppl_1.3170.3170

Published: 2017

Journal Articles

Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients

Cody Ramirez, BS, Kilannin Krysiak, PhD, Felicia Gomez, PhD, Susanna Kiwala, Christopher A. Miller, PhD, Katie Campbell, Jasreet Hundal, Jason Walker, Malachi Griffith, PhD, Obi Griffith, Todd A. Fehniger, MDPhD

Blood (2017) 130 (Supplement 1): 114.

https://doi.org/10.1182/blood.V130.Suppl_1.114.114

Published: 2017

Journal Articles

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

Blood (2017) 130 (Supplement 1): 2678.

https://doi.org/10.1182/blood.V130.Suppl_1.2678.2678

Published: 2017

Journal Articles

An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies

Blood (2017) 130 (Supplement 1): 844.

https://doi.org/10.1182/blood.V130.Suppl_1.844.844

Published: 2017

Journal Articles

Cellular Stressors Contribute to the Expansion of Multiple Hematopoietic Clones of Varying Leukemic Potential

Blood (2017) 130 (Supplement 1): 469.

https://doi.org/10.1182/blood.V130.Suppl_1.469.469

Published: 2017

Journal Articles

Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant

Meagan Jacoby, MD PhD, Eric J. Duncavage, MD, Gue Su Chang, PhD, Christopher A Miller, PhD, Jin Shao, Kevin Elliot, Joshua Robinson, Robert S Fulton, Catrina Fronick, Michelle O'Laughlin, Daniel C. Link, MD, John F DiPersio, MD PhD, Peter Westervelt, MDPhD, Timothy James J Ley, MD, Timothy Aaron Graubert, MD, Matthew J. Walter, MD

Blood (2017) 130 (Supplement 1): 4232.

https://doi.org/10.1182/blood.V130.Suppl_1.4232.4232

Published: 2017

Journal Articles

Ultra-Deep Sequencing As a Predictive Tool for MDS Progression after Allogeneic Hematopoietic Cell Transplant

Eric J. Duncavage, MD, Meagan Jacoby, MD PhD, Gue Su Chang, PhD, Christopher A Miller, PhD, Natasha Edwin, MD, Geoffrey L. Uy, MD, Joshua Robinson, Haley J Abel, PhD, Jin Shao, Kevin Elliot, Robert Fulton, Catrina Fronick, Michelle O'Laughlin, John F DiPersio, MD PhD, Timothy J Ley, MD, Kathryn Trinkaus, PhD, Timothy Aaron Graubert, MD, Matthew J. Walter, MD

Blood (2017) 130 (Supplement 1): 1669.

https://doi.org/10.1182/blood.V130.Suppl_1.1669.1669

Published: 2017

Journal Articles

Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia

Stephen T. Oh, MD PhD, Christopher A. Miller, PhD, Yevgeniy Gindin, PhD, Taylor M. Brost, Jason Chan, MD PhD, Mary C. Fulbright, Daniel A.C. Fisher, PhD, Eric J. Duncavage, MD, Michelle O'Laughlin, Malachi Griffith, PhD, Obi L. Griffith, PhD, Lukas D. Wartman, MD

Blood (2016) 128 (22): 5496.

https://doi.org/10.1182/blood.V128.22.5496.5496

Published: 2016

Journal Articles

Dynamic Changes in MDS Clonal Architecture Following Allogeneic Stem Cell Transplant

Meagan A. Jacoby, MD PhD, Eric J. Duncavage, MD, Gue Su Chang, PhD, Christopher A. Miller, PhD, Jin Shao, Kevin Elliott, Robert S. Fulton, PhD, Catrina Fronick, Michelle O'Laughlin, Daniel C. Link, MD, John F DiPersio, MD PhD, Peter Westervelt, MD PhD, Timothy J. Ley, MD, Timothy A. Graubert, MD, Matthew J. Walter, MD, Richard K Wilson, PhD

Blood (2016) 128 (22): 5506.

https://doi.org/10.1182/blood.V128.22.5506.5506

Published: 2016

Journal Articles

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Blood (2015) 126 (23): 610.

https://doi.org/10.1182/blood.V126.23.610.610

Published: 2015

Journal Articles

Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients

Terrence Neal Wong, MDPhD, Jeffery M. Klco, MDPhD, Ryan Demeter, Christopher A. Miller, PhD, Allegra Petti, PhD, Nichole Havey, Robert Fulton, PhD, Sharon Heath, Elaine R Mardis, PhD, Peter Westervelt, MD PhD, John F. DiPersio, MD PhD, Matthew J. Walter, MD, John S. Welch, MD PhD, Timothy Graubert, MD, Richard K Wilson, PhD, Timothy J. Ley, MD, Daniel C. Link, MD

Blood (2015) 126 (23): 686.

https://doi.org/10.1182/blood.V126.23.686.686

Published: 2015

Journal Articles

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Blood (2015) 126 (23): 689.

https://doi.org/10.1182/blood.V126.23.689.689

Published: 2015

NARROW

Molecular Profiling of Decitabine Response in MDS and AML Patients

Signaling Gene Mutations Are Characterized By Diverse Patterns of Expansion and Contraction during Progression from MDS to Secondary AML

Gata2 Expression and Function in PML-RARA- driven Preleukemia and APL

DNMT3A R882 Alters the Epigenome of Hematopoietic Cells

The Molecular Basis of Long First Remissions in Normal Karyotype AML Patients

The Role of Transcription Factor and Signaling Gene Mutations in the Clonal Evolution of MDS to Secondary AML

Direct Detection of Expressed Mutations in AML Cells Using Single Cell RNA-Sequencing, and Its Impact on Defining Sources of Expression Heterogeneity

Evidence for Complete Mutation Clearance in Normal Karyotype AML Patients with Very Long (> 5 years) Remissions after Chemotherapy Alone

Generation and Characterization of Murine Allogeneic T Cell Resistant APL Cells

Integration of Whole Exome and RNA Sequencing Identifies Neoepitope Vaccine Candidates in >90 Percent of Follicular Lymphoma Patients

Downregulation of MHC Class II in Relapsed AML Cells after Allogeneic Transplantation

An Off-the-Shelf™ Fratricide-Resistant CAR-T for the Treatment of T Cell Hematologic Malignancies

Cellular Stressors Contribute to the Expansion of Multiple Hematopoietic Clones of Varying Leukemic Potential

Subclonal Evolution Characterizes MDS Disease Progression Following Allogeneic Stem Cell Transplant

Ultra-Deep Sequencing As a Predictive Tool for MDS Progression after Allogeneic Hematopoietic Cell Transplant

Clonal Evolution Revealed By Exome Sequencing in a Case of Primary Myelofibrosis Associated with Subsequent Development of Aggressive Systemic Mastocytosis/Mast Cell Leukemia

Dynamic Changes in MDS Clonal Architecture Following Allogeneic Stem Cell Transplant

Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy

Non-Malignant Oligoclonal Hematopoiesis Commonly Follows Cytoreductive Chemotherapy in Adult De Novo AML Patients

Dynamic Changes in Clonal Clearance with Decitabine Therapy in AML and MDS Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only